Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex- and omics-guided opioid treatment in chronic low back pain
2021-001238-21Phase 4Active
- Sponsor
- ISABIAL
- Start
- Jun 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of morphine, fentanyl and tramadol in chronic low back pain (CLBP) (2 arms), sponsored by ISABIAL. Primary endpoint: Metabolic profile by CYP2D6 activity. Started Jun 2021; status: active.
02
Drugs
morphinefentanyltramadol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2021-001238-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001238-21.